ZS Stock Whipsaws After Earnings Beat And Slower FY27 Outlook

Zscaler Inc. stocks have been trading up by 9.75 percent amid upbeat analyst upgrades and strong cybersecurity growth expectations.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading ZS

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Fiscal Q3 from Zscaler blew past expectations, with 25% revenue and ARR growth, $850.5M in revenue, and a record 23% non-GAAP operating margin powering a profitable-growth story.
Management nudged FY26 guidance for EPS, revenue, and ARR higher but cut free cash flow margin on heavier capex, sending mixed signals to ZS traders.
Shares of ZS sank roughly 20% after the call as preliminary FY27 ARR and revenue growth of 16%–17% landed below prior Street expectations near 18.4%.
Major firms including JPMorgan, Truist, B. Riley, RBC, Berenberg, Deutsche Bank, KeyBanc, and UBS trimmed price targets into roughly the $175–$215 band while sticking with Buy/Overweight stances.
Zscaler is pushing deeper into AI security with the planned Symmetry Systems buy, adding tools to secure AI agents and data access across large enterprises.

Live Update At 10:03:30 EDT: On Monday, June 01, 2026 Zscaler Inc. stock [NASDAQ: ZS] is trending up by 9.75%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

ZS just reminded the market it is a growth name that trades like a momentum stock. On the tape, the daily chart shows a violent round-trip: Zscaler closed at $184.60 on 2026/05/26 before the earnings fallout, then flushed into the low $120s on 2026/05/27, and has since bounced back toward the mid-$150s, finishing 2026/06/01 around $153.78. That’s a huge volatility pocket for active trading.

Under the hood, Zscaler’s fundamentals back up the big moves. Revenue over the last year sits around $2.67B, growing more than 30% annually over three and five years. Q3 revenue was $850.5M, up 25% year over year, with ARR also growing 25% to roughly $3.53B. Gross margin is a rich 76.5%, showing strong pricing power and a scalable cloud model, even though GAAP profit margins remain slightly negative.

ZS still posts a small net loss, but cash flow tells a different story. Operating cash flow last quarter was about $198M, with free cash flow near $136M after capex. The balance sheet looks solid: current ratio around 1.9, quick ratio 1.7, and manageable leverage with total debt-to-equity at 0.85 and interest coverage of 9.7. For traders, that combination — high growth, strong gross margins, and healthy cash generation — is classic fuel for sharp reratings when expectations shift.

More Breaking News

Intraday, the 5‑minute chart on 2026/06/01 shows ZS grinding higher from premarket levels near $142 to a regular-session push above $154, then consolidating around $153–$154 into 10:00. That’s a clean trend day, exactly the kind of structure momentum traders hunt after a sentiment reset.

Why Traders Are Watching ZS Now

ZS is in the classic “great quarter, tricky guide” setup. The company beat fiscal Q3 expectations on both EPS and revenue, printed record 23% non-GAAP operating margins, and still saw its stock get punished. Revenue of $850.5M crushed the $835.6M consensus, and ARR growth at 25% — roughly 21% organically excluding Red Canary — confirms Zscaler is still landing big security deals at scale.

Then came the speed bump. Management raised FY26 guidance for revenue, ARR, and adjusted EPS, but trimmed the free cash flow margin outlook thanks to higher capex. For ZS traders, that says one thing: near-term cash yield gets pressured as the company reinvests, especially into AI-infused security and its global platform.

The real shock was further out. Zscaler introduced preliminary FY27 ARR and revenue growth expectations in the 16%–17% range, below the ~18.4% the Street had been modeling. That gap doesn’t sound huge on paper, but for a premium-multiple name like ZS, those two percentage points were enough to trigger a roughly 20% post-earnings air pocket as fast money bailed.

Analysts largely echoed the same theme. Truist, JPMorgan, B. Riley, RBC, Berenberg, and Deutsche Bank all cut price targets — generally into the $175–$215 range — while keeping Buy, Overweight, or Outperform ratings on ZS. JPMorgan’s move from $250 to $205 and Truist’s cut to $200 framed FY27 as slower but “de‑risked.” B. Riley flagged softer new-logo growth and sales leadership changes, yet pointed to more than $100M in AI security bookings and 30%+ data security growth as proof that demand is not the issue.

At the same time, UBS stuck with a Buy and a $260 target, highlighting improving demand checks, new federal wins, and growing AI-driven security needs, especially as ZS had already lagged the cybersecurity group by about 22% year to date pre-print. Add in the planned acquisition of AI security specialist Symmetry Systems — plus prior Red Canary and AI-Guardian initiatives — and Zscaler is clearly positioning itself as a core AI-era Zero Trust platform.

For active traders, that mix is powerful. You have a stock with strong fundamentals, heavy AI exposure, compressed sentiment, and wide price-target dispersion. That usually translates into big, tradeable swings as ZS toggles between fear of slowing growth and optimism around long-term AI security demand.

Conclusion

ZS is in the penalty box short term, but the game is far from over. The stock’s collapse from the $180s into the $120s after earnings shows just how unforgiving the market is when a high-multiple name talks about slower growth and lower free cash flow margin, even after a big beat. Yet the rebound back toward $150+ suggests traders are already probing for where the new equilibrium lives.

On the fundamentals, Zscaler is still delivering what growth-oriented traders want to see: 25% revenue and ARR expansion, fat 76.5% gross margins, rising operating leverage, and meaningful free cash flow. The capex ramp that pressured guidance is funding data centers, AI capabilities, and acquisitions like Symmetry Systems, all tied directly to defending a leading role in Zero Trust and AI security.

Analyst moves around ZS tell the same story in numbers. Price targets shifted down aggressively — Berenberg from $320 to $200, JPMorgan to $205, Truist to $200, Deutsche Bank to $175 — but ratings stayed positive. The Street is recalibrating expectations, not walking away. For traders, that reset often creates a fresh trading range rather than a broken story.

This is where discipline matters. Tim Sykes has said for years, “Volatile stocks are the best teachers — if you respect the risk, cut losses fast, and never fall in love with the story.” As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.” ZS is exactly that kind of teacher right now. Use the volatility, study the chart around these new growth expectations, and remember this article is for educational and research purposes only — not trading advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!